Table 4 Mid-term follow-up of hybrid or TAR + FET group in the PSM and IPTW cohorts
Outcomes | Hybrid | TAR + FET | HR (95% CI) | P value |
|---|---|---|---|---|
PSM Cohort | N = 121 | N = 121 | ||
Death from all causes | 20.2 (10.4–28.7) | 20.5 (9.7–29.9) | 1.09 (0.48–1.74) | 0.782 |
Stroke | 11.5 (5.8–19.5) | 7.1 (3.3–12.9) | 0.72 (0.29–1.81) | 0.494 |
Aortic re-intervention | 9.2 (4.2–16.6) | 1.7 (0.3–5.4) | 0.21 (0.05–0.97) | 0.029 |
IPTW Cohort | N = 136 | N = 415 | ||
Death from all causes | 21.5 (12.7–29.3) | 20.4 (7.9–31.1) | 0.59 (0.32–1.12) | 0.108 |
Stroke | 12.5 (5.4–19.1) | 11.1 (6.8–15.2) | 0.81 (0.38–1.76) | 0.590 |
Aortic re-intervention | 11.6 (4.7–17.9) | 4.8 (0.1–8.5) | 0.12 (0.05–0.29) | < 0.001 |